US FDA rejects broader arthritis use of Janssen Biotech's Simponi
13 September 2011
Donna Young
Please Login to read the full article.
13 September 2011
Donna Young
Please Login to read the full article.
RELATED CONTENT
NEWS
- Simponi positive in Phase III for ulcerative colitis
- MTP looks to Simponi to secure dominant rheumatoid arthritis position in Japan
- NICE provisionally and conditionally recommends Simponi for ankylosing spondylitis
- Humira passes post-marketing muster in Japan psoriasis setting
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
